58 related articles for article (PubMed ID: 8619498)
1. High-performance liquid chromatographic assay for tryptase based on the hydrolysis of dansyl-vasoactive intestinal peptide.
Delaria K; Muller D
Anal Biochem; 1996 Apr; 236(1):74-81. PubMed ID: 8619498
[TBL] [Abstract][Full Text] [Related]
2. Substance P and vasoactive intestinal peptide degradation by mast cell tryptase and chymase.
Caughey GH; Leidig F; Viro NF; Nadel JA
J Pharmacol Exp Ther; 1988 Jan; 244(1):133-7. PubMed ID: 2447273
[TBL] [Abstract][Full Text] [Related]
3. Histone-tryptase interaction: H2A N-terminal tail removal and inhibitory activity.
Fiorucci L; Erba F; Ascoli F
Arch Biochem Biophys; 1997 Nov; 347(2):229-34. PubMed ID: 9367529
[TBL] [Abstract][Full Text] [Related]
4. Mast cell tryptase and chymase in chronic leg ulcers: chymase is potentially destructive to epithelium and is controlled by proteinase inhibitors.
Huttunen M; Harvima IT
Br J Dermatol; 2005 Jun; 152(6):1149-60. PubMed ID: 15948975
[TBL] [Abstract][Full Text] [Related]
5. Bis(5-amidino-2-benzimidazolyl)methane and related amidines are potent, reversible inhibitors of mast cell tryptases.
Caughey GH; Raymond WW; Bacci E; Lombardy RJ; Tidwell RR
J Pharmacol Exp Ther; 1993 Feb; 264(2):676-82. PubMed ID: 8437115
[TBL] [Abstract][Full Text] [Related]
6. Guinea pig lung tryptase. Localisation to mast cells and characterisation of the partially purified enzyme.
McEuen AR; He S; Brander ML; Walls AF
Biochem Pharmacol; 1996 Jul; 52(2):331-40. PubMed ID: 8694858
[TBL] [Abstract][Full Text] [Related]
7. Degradation of airway neuropeptides by human lung tryptase.
Tam EK; Caughey GH
Am J Respir Cell Mol Biol; 1990 Jul; 3(1):27-32. PubMed ID: 1694672
[TBL] [Abstract][Full Text] [Related]
8. Mast cell tryptase stimulates the synthesis of type I collagen in human lung fibroblasts.
Cairns JA; Walls AF
J Clin Invest; 1997 Mar; 99(6):1313-21. PubMed ID: 9077541
[TBL] [Abstract][Full Text] [Related]
9. Inactivation of human lung tryptase: evidence for a re-activatable tetrameric intermediate and active monomers.
Addington AK; Johnson DA
Biochemistry; 1996 Oct; 35(42):13511-8. PubMed ID: 8885830
[TBL] [Abstract][Full Text] [Related]
10. Human mast cell tryptase isoforms: separation and examination of substrate-specificity differences.
Little SS; Johnson DA
Biochem J; 1995 Apr; 307 ( Pt 2)(Pt 2):341-6. PubMed ID: 7733867
[TBL] [Abstract][Full Text] [Related]
11. [Comparison of biochemical properties of human airway tryptase isolated from mucoid sputum with those of lung mast cell tryptase].
Yasuoka S; Tsuchihashi S; Kurokawa M; Terao T; Yoshinaga T; Kawano S; Takekawa Y; Nakayama T; Doi H; Ogawara M
Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Jun; 34(6):678-84. PubMed ID: 8741534
[TBL] [Abstract][Full Text] [Related]
12. Structural examination of tryptase-, and VIP-positive mast cells in the common bile duct of patients with lithiasis.
Gulubova M; Vodenicharov A
Acta Histochem; 2001 Oct; 103(4):437-52. PubMed ID: 11700949
[TBL] [Abstract][Full Text] [Related]
13. Identification and characterization of multiple forms of tryptase from human mast cells.
Harvima RJ; Harvima IT; Dull D; Dunder UK; Schwartz LB
Arch Dermatol Res; 1999; 291(2-3):73-80. PubMed ID: 10195393
[TBL] [Abstract][Full Text] [Related]
14. A role for tryptase in the activation of human mast cells: modulation of histamine release by tryptase and inhibitors of tryptase.
He S; Gaça MD; Walls AF
J Pharmacol Exp Ther; 1998 Jul; 286(1):289-97. PubMed ID: 9655871
[TBL] [Abstract][Full Text] [Related]
15. Recombinant human mast cell tryptase beta: stable expression in Pichia pastoris and purification of fully active enzyme.
Niles AL; Maffitt M; Haak-Frendscho M; Wheeless CJ; Johnson DA
Biotechnol Appl Biochem; 1998 Oct; 28 ( Pt 2)():125-31. PubMed ID: 9756742
[TBL] [Abstract][Full Text] [Related]
16. Inhibitors of tryptase as mast cell-stabilizing agents in the human airways: effects of tryptase and other agonists of proteinase-activated receptor 2 on histamine release.
He S; Aslam A; Gaça MD; He Y; Buckley MG; Hollenberg MD; Walls AF
J Pharmacol Exp Ther; 2004 Apr; 309(1):119-26. PubMed ID: 14722328
[TBL] [Abstract][Full Text] [Related]
17. Reaction of mast cell proteases tryptase and chymase with protease activated receptors (PARs) on keratinocytes and fibroblasts.
Schechter NM; Brass LF; Lavker RM; Jensen PJ
J Cell Physiol; 1998 Aug; 176(2):365-73. PubMed ID: 9648924
[TBL] [Abstract][Full Text] [Related]
18. Neutrophil myeloperoxidase is a potent and selective inhibitor of mast cell tryptase.
Cregar L; Elrod KC; Putnam D; Moore WR
Arch Biochem Biophys; 1999 Jun; 366(1):125-30. PubMed ID: 10334872
[TBL] [Abstract][Full Text] [Related]
19. Proteolytic susceptibility of the serine protease inhibitor trappin-2 (pre-elafin): evidence for tryptase-mediated generation of elafin.
Guyot N; Zani ML; Berger P; Dallet-Choisy S; Moreau T
Biol Chem; 2005 Apr; 386(4):391-9. PubMed ID: 15899702
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of tryptase and chymase induced nucleated cell infiltration by proteinase inhibitors.
He SH; Chen HQ; Zheng J
Acta Pharmacol Sin; 2004 Dec; 25(12):1677-84. PubMed ID: 15569415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
